Skip to content

DR. PIETER VANDERSCHAEVE

Active
Private limited companyfounded 2007active for 18 yearsCorpusstraat 75, 9700 Oudenaarde, BelgiumKBO/BCE: BE 0893.993.372
Summary

DR. PIETER VANDERSCHAEVE has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €395,240 and a net result of €53,001. Equity is growing by about 7.4% per year across the filed financial years. Its solvency ranks better than 87% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR. PIETER VANDERSCHAEVEActiveChecked score 95/100
Risk analysis ReportCompare

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€428,772total assets 2025
Equity
€395,240
Profit
€53,001
Turnover not published (micro format)
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 25 days early1 deed in the Belgian Official Gazette
Why 95lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 14.64, cash €106,100Equity €395,240 (92.2% of total assets)Size: total assets €428,772Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 58% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 92.2% of total assets
Liquidity 81-10
short-term debt 6.4% · cash 24.7%
Profitability 84+4
return on assets 12.4%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025highest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity ample (current ratio 14.64, compared with 7.09 in 2024, above the usual 1.5; short-term debt: 6.4% and cash: 24.7% of total assets), and 7.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 63% on liquidity, 34% on profitability and 53% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 14.64, cash €106,100
NBB · annual accounts
lowers risk · Equity €395,240 (92.2% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €428,772
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 06-01-2026, 25 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
25 days early
2024
11 days early
2023
43 days early
2022
43 days early
2021
41 days early
2020
26 days early
2019
28 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 31 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 21 December (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end26-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Liquidity more than doubledcurrent ratio 14.64
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Among the best 13% on solvencysector median 63.0% · 20,612 companies 92.2% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €53,001 7 years View

By topic

Financials

Financial year
2025
Total assets
€428,772
Profit
€53,001
Solvency
92.2%
Total assets▲ 2.5%
Net result
20192025
Go to Financials

Timeline

Events
21
Since
2010
Next accounts
by 31-01-2027
  1. 30-06-2024Weakest financial year
  2. 19-12-2023Annual accounts filed
  3. 30-06-2023Highest result from 2019 to 2025
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
06-12-2007
Year ends
30-06
Peppol
Not found in the Peppol directory
Go to Company details

Key facts about DR. PIETER VANDERSCHAEVE

What is the company number of DR. PIETER VANDERSCHAEVE?
0893.993.372. In Belgium the VAT number is the company number with BE in front: BE 0893.993.372.
Where is DR. PIETER VANDERSCHAEVE based?
The registered office is at Corpusstraat 75, 9700 Oudenaarde.Company details
What does DR. PIETER VANDERSCHAEVE do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. PIETER VANDERSCHAEVE?
Private limited company (BV).
When was DR. PIETER VANDERSCHAEVE founded?
On 06-12-2007.
Is DR. PIETER VANDERSCHAEVE still active?
Yes, DR. PIETER VANDERSCHAEVE is an active enterprise in the KBO register.
What is the turnover of DR. PIETER VANDERSCHAEVE?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR. PIETER VANDERSCHAEVE profitable?
In financial year 2025, DR. PIETER VANDERSCHAEVE made a profit of €53,001.
Where can I find the annual accounts of DR. PIETER VANDERSCHAEVE?
DR. PIETER VANDERSCHAEVE filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. PIETER VANDERSCHAEVE due?
By 31-01-2027, for financial year 2026.Timeline

Companies related to DR. PIETER VANDERSCHAEVE

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure